Results 101 to 110 of about 230,292 (304)
What's New? Hypoxic regions and inflammatory Th17 cells in the tumor environment are both associated with poor prognosis in cervical cancer. However, synergistic mechanisms between hypoxia and Th17 cells remain elusive. This study demonstrated Th17–hypoxia‐driven mechanisms underlying cervical cancer progression.
Selina Gies +12 more
wiley +1 more source
Recurrence of cervical precancer after excisional treatment: risks and prevention
Background. Genital papillomavirus infection is widespread in the population, initiating the development of precancer and genital cancer. The vast majority (83.0%) of human papillomavirus-related cancer cases worldwide are cervical cancer.
T. V. Klinyshkova, M. S. Buyan
doaj +1 more source
What's New? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon +2 more
wiley +1 more source
Background Aside from personal beliefs, women’s intention to uptake human papillomavirus vaccination can be influenced by their perceived risks of developing cervical cancer and daily communication.
Li Li, Jinhui Li
doaj +1 more source
Congenital cutaneous fibropapillomatosis in a warmblood foal [PDF]
In this report, clinical and histological findings of a rare case of a large congenital fibropapilloma on the forehead of a warmblood foal are reported. Surgical excision was curative and no recurrence was observed after nine months.
de Cock, Hilde +5 more
core +1 more source
What's New? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll +11 more
wiley +1 more source
What's New? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita +13 more
wiley +1 more source
Vaccines in Current Culture: The HPV Vaccine Controversy [PDF]
The use of vaccinations has drastically decreased mortality and morbidity rates related to infectious disease and has become an intrinsic part of modern health care.
Johnston, Alyssa
core +1 more source

